Press release
Growth Dynamics on Extracorporeal Membrane Oxygenation Market| Key Players: Kalila Medical, ALung Technologies, Braile Biomédica
The Extracorporeal Membrane Oxygenation Market is set to exceed USD 357 million by 2024; according to a new research study published by Global Market Insights, Inc.
Increase in cases of cardiopulmonary diseases and respiratory failure in Asia Pacific region will propel the extracorporeal membrane oxygenation market over the forecast timeframe. Currently there are around 4.2 million people with heart failure in China and around 1 million people in Japan. High patient population, developing healthcare infrastructure and high prevalence of cardiopulmonary disorders will lead to industry growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2720
Venoarterial (VA) modality accounted for majority of market with a value of USD 124.6 million in 2017. Recent technological advancement in mechanical circulation has resulted in quality and survival of increasing number of patients suffering from advanced heart failure and other cardiopulmonary disorders. Increase in use of veno-arterial (VA) ECMO in patients with several aetiology of cardiogenic shock will drive the demand for venoarterial ECMO.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Kalila Medical
• ALung Technologies
• Braile Biomédica
• Edwards Lifesciences
• Eurosets
• Maquet Getinge Group
• LivaNova
• Visualase, Inc.
• Microport Scientific Corp
• Nipro Medical Corporation
• OriGen Biomedical
• Spectrum Medical Ltd
• Terumo Medical Corporation
Veno-venous ECMO (VV-ECMO) modality is estimated to witness considerable growth in the projection period at a CAGR of 3.3%. It is the treatment of choice for the patients with conventional medical treatments and for patients with respiratory failure and optimal mechanical ventilation. Though veno-venous ECMO is complex technique and poses substantial risks, it provides complete respiratory support for the patients increasing the survival rate. Aforementioned factors will be responsible for the business growth in the future.
ECMO application in respiratory diseases held the majority of market share, accounting for around USD 168.8 million in 2017. According to World Health Organization, more than 3 million people die each year from chronic obstructive pulmonary disease (COPD), accounting for over 6% of the total global deaths. ECMO has exceptionally progressed in the last few years and has become an invaluable tool in the care of patients with respiratory disorders. Increase in use of ECMO in treatment of children and adults with severe respiratory diseases will propel the industry growth in upcoming years.
Adult patient population subjected to ECMO use will witness significant growth at a CAGR of 4.6% from 2018 to 2024. ECMO has been widely used in treatment of both cardiac and respiratory failure and is invaluable and viable therapy for adults. According to Johns Hopkins Health System, heart disease is the most serious health problem in U.S., with an estimated 15 million adults suffering coronary heart disease. Hence, increase in adult patients with severe cardiac and respiratory failure introduced to ECMO early in the course of diseases will boost the market growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2720
U.S. dominated North America ECMO market with a value of USD 94.9 million in 2017. According to American Lung Association, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in the Unites states, with more than 11 million people diagnosed with COPD. Ongoing technological advancements leading to production of superior ECMO devices and increase in number of people suffering from cardiac and respiratory disorders will lead to U.S. retaining higher market share over the forecast timeframe.
Extracorporeal Membrane Oxygenation Market by Modality
• Venoarterial (VA)
• Veno-venous (VV)
• Arteriovenous (AV)
Extracorporeal Membrane Oxygenation Market by Application
• Cardiac
• Respiratory
• Extracorporeal cardiopulmonary resuscitation (ECPR)
lobal Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
Increase in cases of cardiopulmonary diseases and respiratory failure in Asia Pacific region will propel the extracorporeal membrane oxygenation market over the forecast timeframe. Currently there are around 4.2 million people with heart failure in China and around 1 million people in Japan. High patient population, developing healthcare infrastructure and high prevalence of cardiopulmonary disorders will lead to industry growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2720
Venoarterial (VA) modality accounted for majority of market with a value of USD 124.6 million in 2017. Recent technological advancement in mechanical circulation has resulted in quality and survival of increasing number of patients suffering from advanced heart failure and other cardiopulmonary disorders. Increase in use of veno-arterial (VA) ECMO in patients with several aetiology of cardiogenic shock will drive the demand for venoarterial ECMO.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Kalila Medical
• ALung Technologies
• Braile Biomédica
• Edwards Lifesciences
• Eurosets
• Maquet Getinge Group
• LivaNova
• Visualase, Inc.
• Microport Scientific Corp
• Nipro Medical Corporation
• OriGen Biomedical
• Spectrum Medical Ltd
• Terumo Medical Corporation
Veno-venous ECMO (VV-ECMO) modality is estimated to witness considerable growth in the projection period at a CAGR of 3.3%. It is the treatment of choice for the patients with conventional medical treatments and for patients with respiratory failure and optimal mechanical ventilation. Though veno-venous ECMO is complex technique and poses substantial risks, it provides complete respiratory support for the patients increasing the survival rate. Aforementioned factors will be responsible for the business growth in the future.
ECMO application in respiratory diseases held the majority of market share, accounting for around USD 168.8 million in 2017. According to World Health Organization, more than 3 million people die each year from chronic obstructive pulmonary disease (COPD), accounting for over 6% of the total global deaths. ECMO has exceptionally progressed in the last few years and has become an invaluable tool in the care of patients with respiratory disorders. Increase in use of ECMO in treatment of children and adults with severe respiratory diseases will propel the industry growth in upcoming years.
Adult patient population subjected to ECMO use will witness significant growth at a CAGR of 4.6% from 2018 to 2024. ECMO has been widely used in treatment of both cardiac and respiratory failure and is invaluable and viable therapy for adults. According to Johns Hopkins Health System, heart disease is the most serious health problem in U.S., with an estimated 15 million adults suffering coronary heart disease. Hence, increase in adult patients with severe cardiac and respiratory failure introduced to ECMO early in the course of diseases will boost the market growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2720
U.S. dominated North America ECMO market with a value of USD 94.9 million in 2017. According to American Lung Association, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in the Unites states, with more than 11 million people diagnosed with COPD. Ongoing technological advancements leading to production of superior ECMO devices and increase in number of people suffering from cardiac and respiratory disorders will lead to U.S. retaining higher market share over the forecast timeframe.
Extracorporeal Membrane Oxygenation Market by Modality
• Venoarterial (VA)
• Veno-venous (VV)
• Arteriovenous (AV)
Extracorporeal Membrane Oxygenation Market by Application
• Cardiac
• Respiratory
• Extracorporeal cardiopulmonary resuscitation (ECPR)
lobal Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
